Defining a Cancer Dependency Map.

Area of Science:

• Cancer research
• Genomics
• Molecular biology

Background:

• Human epithelial tumors possess numerous genetic alterations, complicating the identification of essential genes for tumor survival.
• Systematic identification of cancer dependencies is crucial for developing effective cancer therapies.

Purpose of the Study:

• To systematically identify genes essential for the survival of diverse human cancer cell lines.
• To develop predictive models for cancer dependencies using molecular features.
• To establish a foundation for a cancer dependency map to prioritize therapeutic targets.

Main Methods:

• Analysis of 501 genome-scale loss-of-function screens in human cancer cell lines.
• Development of the DEMETER analytical framework to distinguish on-target from off-target RNAi effects.
• Application of nonlinear regression modeling using 66,646 molecular features to build predictive models for gene dependencies.

Main Results:

• Identification of 769 genes differentially required in subsets of cancer cell lines.
• Development of predictive models for 426 (55%) identified dependencies.
• Discovery that expression-based biomarkers are the primary predictors in 82% of the models.
• Demonstration of a predictive model linking UBB gene hypermethylation to UBC dependency.

Conclusions:

• The study provides a comprehensive analysis of cancer dependencies across a large dataset of cell lines.
• Expression-based biomarkers are key predictors of cancer dependencies, offering insights into therapeutic strategies.
• The findings lay the groundwork for a cancer dependency map to guide the development of targeted cancer therapies.